Risk factors deciding the prevention and healing of diabetic foot ulcer: a prospective study in Chennai Medical College Hospital and Research Center Irungalur, Trichy, Tamil Nadu, India; a rural based tertiary medical care centre

Authors

  • R. Murugan Department of Surgery, Chennai Medical College Hospital and Research Center, Irungalur, Trichy, Tamil Nadu, India
  • S. Padma Department of Surgery, Chennai Medical College Hospital and Research Center, Irungalur, Trichy, Tamil Nadu, India
  • M. Senthilkumaran Department of Surgery, Chennai Medical College Hospital and Research Center, Irungalur, Trichy, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2349-2902.isj20181459

Keywords:

Diabetes mellitus, Diabetic foot ulcer, HbA1c, Microangiopthy, Retinopathy

Abstract

Background: Diabetic foot ulcer is the one among and the most common complication of diabetes mellitus patients. Various studies from over the world for the past 2 decades discuss the important risk factors that decide the prevention and outcome of diabetic foot ulcer. In our prospective study we have discussed the risk factors focused on prevention and treatment of diabetic foot ulcer in a rural tertiary medical care centre.

Methods: Totally 940 patients with the clinical diagnosis of diabetic foot ulcer admitted in our hospital surgical department were studied prospectively with their clinical symptoms and signs of diabetic foot ulcer and various evaluations done for the comorbid conditions with the help of other specialty departments. All these risk factors studied in our rural based tertiary medical centre were collected in a designed format were studied and discussed in comparison to the chosen data available in various studies done at various countries.

Results: All the 940 patients admitted for diabetic foot ulcer who underwent a methodical evaluation for risk factor showed an elevated HbA1c more than 8 in 720 (77.5%) patients, bony involvement like osteomyelitis in 274 patients (29%) , peripheral vascular disease in 421 (44.9%), neuropathy in 533 patients (56.7%), nephropathy 163 (17.34%), retinopathy in 102 (10.85%) and heart disease in 375 (39.89%).

Conclusions: Proper protocols to the prevention and management of foot ulcer in diabetic patients have not reached many health care centres and it is imperative to stress on the related comorbid risk factors which influence the prevention and healing of diabetic foot ulcer. Present study done at a rural tertiary health care centre is mainly focused on the incidence of risk factors which modulates and modify the diabetic foot ulcer prevention and management. This study aims to support the health professionals to identify the risk factors apart from the clinical picture of diabetic foot ulcer that may enhance the efficient management and avoid the unnecessary morbidity and mortality.

 

References

Shahbazian H, Yazdanpanah L, Latifi SM. Risk assessment of patients with diabetes for foot ulcers according to risk classification consensus of International Working Group on Diabetic Foot (IWGDF). Pak J Med Sci. 2013;29:730-4.

Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Trends in prevalence of diabetes in Asian countries. World J Diab. 2012;3:110-7.

Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4-14.

Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311-21.

Aalaa M, Malazy OT, Sanjari M, Peimani M, Mohajeri-Tehrani M. Nurses’ role in diabetic foot prevention and care; a review. J Diabetes Metab Disord. 2012;11:24.

Alavi A, Sibbald RG, Mayer D, Goodman L, Botros M, Armstrong DG et al. Diabetic foot ulcers: Part II. Management. J Am Acad Dermatol. 2014;70:21.

Cavanagh PR, Lipsky BA, Bradbury AW, Botek G. Treatment for diabetic foot ulcers. The Lancet. 2005 Nov 12;366(9498):1725-35.

Iraj B, Khorvash F, Ebneshahidi A, Askari G. Prevention of diabetic foot ulcer. Int J Prev Med. 2013;4:373-6.

Fard AS, Esmaelzadeh M, Larijani B. Assessment and treatment of diabetic foot ulcer. Int J Clin Pract. 2007;61:1931-8.

Snyder RJ, Hanft JR. Diabetic foot ulcers--effects on QOL, costs, and mortality and the role of standard wound care and advanced-care therapies. Ostomy Wound Manage. 2009;55:28-38.

Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Kravitz SR et al. Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg. 2006;45:S1-66.

Bortoletto MS, de Andrade SM, Matsuo T, Haddad Mdo C, González AD, Silva AM. Risk factors for foot ulcers--a cross sectional survey from a primary care setting in Brazil. Prim Care Diab. 2014;8:71-6.

Waaijman R, de Haart M, Arts ML, Wever D, Verlouw AJ, Nollet F et al. Risk factors for plantar foot ulcer recurrence in neuropathic diabetic patients. Diabetes Care. 2014;37:1697-1705.

Monteiro-Soares M, Boyko EJ, Ribeiro J, Ribeiro I, Dinis-Ribeiro M. Predictive factors for diabetic foot ulceration: a systematic review. Diabetes Metab Res Rev. 2012;28:574-600.

Schaper NC. Lessons from eurodiale. Diabetes/metabolism Res Rev. 2012 Feb 1;28(S1):21-6.

Reiber GE, Vileikyte LO, Boyko ED, Del Aguila M, Smith DG, Lavery LA et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes care. 1999 Jan 1;22(1):157-62.

Apelqvist J, Bakker K, Van Houtum WH, Schaper NC. Practical guidelines on the management and prevention of the diabetic foot. Diabetes/Metabolism Res Rev. 2008 May 1;24(S1).

Yazdanpanah L, Nasiri M, Adarvishi S. Literature review on the management of diabetic foot ulcer. World J Diab. 2015 Feb 15;6(1):37.

Gershater MA, Löndahl M, Nyberg P, Larsson J, Thörne J, Eneroth M et al. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia. 2009 Mar 1;52(3):398-407.

Ulbrecht JS, Wukich DK. The Charcot Foot: medical and surgical therapy. Curr Diab Rep 2008,8:444-51.

De Souza LJ. Charcot Arthropathy and Immobilization in a Weight-Bearing Total Contact Cast.J Bone Joint Surg. 2008;90(4):754-9.

Vella S, Cachia MJ. Charcot neuroarthropathy: pathogenesis diagnosis and medical management. Malta Med J. 2008;20(3):13-19.

Beckert S, Witte M, Wicke C, Königsrainer A, Coerper S. A new wound-based severity score for diabetic foot ulcers: a prospective analysis of 1,000 patients. Diabetes Care. 2006 May;29(5):988-92.

Pakarinen TK, Laine HJ, Maenpaa H, Mattila P, Lahtela J. Long-term outcome and quality of life in patients with Charcot foot. Foot Ankle Surg. 2009;15:187-191.

Bowering CK. Diabetic foot ulcers. Pathophysiology, assessment, and therapy. Can Fam Physician. 2001;47:1007-16.

McMurry JF. Wound healing with diabetes mellitus. Better glucose control for better wound healing in diabetes. Surg Clin North Am. 1984;64:769-78.

UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). The Lancet. 1998 Sep 12;352(9131):854-65.

Stuck RM, Sohn MW, Budiman E, Lee TA, Weiss KB. Charcot Arthropathy Risk Elevation in the Obese Diabetic Population. Am J Med. 2008;121(11):1009-14.

Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006;29:1288-93.

Rogers LC, Bevilacqua NJ. Imaging of the Charcot Foot. Clin Podiatr Med Surg. 2008;25:263-74.

Anderson LB, DiPreta J. Charcot of the Calcaneous. Foot Ankle Clin. 2006;11:825-35.

Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale Study. Diabetologia. 2007;50:18-25.

Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P, Showstack JA. Lower-extremity amputation in people with diabetes. Epidemiology and prevention. Diabetes Care. 1989;12:24-31.

Tomita M, Kabeya Y, Okisugi M, Katsuki T, Oikawa Y, Atsumi Y, Matsuoka K, Shimada A. Diabetic microangiopathy is an independent predictor of incident diabetic foot ulcer. J Diabetes Res. 2016;2016:5938540.

Fernando DJ, Hutchison A, Veves A, Gokal R, Boulton AJ. Risk Factors for Non‐ischaemic Foot Ulceration in Diabetic Nephropathy. Diabetic medicine. 1991 Apr;8(3):223-5.

Guerrero-Romero F, Rodrı́guez-Morán M. Relationship of microalbuminuria with the diabetic foot ulcers in type II diabetes. J Diab Complications. 1998 Jul 1;12(4):193-6.

Downloads

Published

2018-04-21

Issue

Section

Original Research Articles